PT98325A - Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna) - Google Patents

Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna)

Info

Publication number
PT98325A
PT98325A PT98325A PT9832591A PT98325A PT 98325 A PT98325 A PT 98325A PT 98325 A PT98325 A PT 98325A PT 9832591 A PT9832591 A PT 9832591A PT 98325 A PT98325 A PT 98325A
Authority
PT
Portugal
Prior art keywords
mesna
tablets
weight
parts
mercaptoethanosulphonate
Prior art date
Application number
PT98325A
Other languages
English (en)
Other versions
PT98325B (pt
Inventor
Juergen Engel
Dieter Sauerbier
Eckhard Milsmann
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of PT98325A publication Critical patent/PT98325A/pt
Publication of PT98325B publication Critical patent/PT98325B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98325A 1990-07-16 1991-07-15 Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna) PT98325B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022525 1990-07-16
SG142394A SG142394G (en) 1990-07-16 1994-10-03 Tablet and granulate containing mesna as active agent

Publications (2)

Publication Number Publication Date
PT98325A true PT98325A (pt) 1992-05-29
PT98325B PT98325B (pt) 1999-01-29

Family

ID=25895027

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98325A PT98325B (pt) 1990-07-16 1991-07-15 Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna)

Country Status (31)

Country Link
US (1) US5262169A (pt)
EP (1) EP0468245B1 (pt)
JP (1) JP3068894B2 (pt)
KR (1) KR100189666B1 (pt)
CN (1) CN1072484C (pt)
AT (1) ATE104548T1 (pt)
AU (1) AU638586B2 (pt)
BG (2) BG60851B1 (pt)
CA (1) CA2047027C (pt)
DE (2) DE4122167A1 (pt)
DK (1) DK0468245T3 (pt)
EG (1) EG20019A (pt)
ES (1) ES2063412T3 (pt)
FI (1) FI97949C (pt)
HK (1) HK129894A (pt)
HR (1) HRP920889B1 (pt)
HU (1) HU206630B (pt)
IE (1) IE65373B1 (pt)
IL (1) IL98836A (pt)
LT (1) LT3527B (pt)
LV (1) LV10040B (pt)
MC (1) MC2273A1 (pt)
MX (1) MX174407B (pt)
NO (1) NO178362C (pt)
NZ (1) NZ238941A (pt)
PT (1) PT98325B (pt)
RO (1) RO113713B1 (pt)
RU (1) RU2070040C1 (pt)
SG (1) SG142394G (pt)
SI (1) SI9111226A (pt)
ZA (1) ZA915515B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2111659T3 (es) * 1992-03-11 1998-03-16 Asta Medica Ag Comprimidos, granulados y nodulos con alto contenido en sustancias activas para formas de administracion solidas de alta concentracion.
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
EP0955040A1 (de) * 1998-04-27 1999-11-10 ASTA Medica Aktiengesellschaft Arzneiform zur oralen Applikation von Mesna
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6075053A (en) * 1999-02-09 2000-06-13 Bionumerik Pharmaceuticals, Inc. Method of reducing or reversing neuropathy
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
SI9111226A (en) 1995-04-30
EP0468245B1 (de) 1994-04-20
IL98836A (en) 1994-11-28
DK0468245T3 (da) 1994-05-16
NO178362C (no) 1996-03-13
CN1072484C (zh) 2001-10-10
MC2273A1 (fr) 1993-06-23
CA2047027A1 (en) 1992-01-17
HUT59317A (en) 1992-05-28
MX174407B (es) 1994-05-13
PT98325B (pt) 1999-01-29
LV10040A (lv) 1994-05-10
IE912463A1 (en) 1992-01-29
FI913409A0 (fi) 1991-07-15
FI97949B (fi) 1996-12-13
HK129894A (en) 1994-12-02
KR100189666B1 (ko) 1999-06-01
AU8044591A (en) 1992-01-16
BG60901B1 (bg) 1996-06-28
ZA915515B (en) 1992-04-29
FI913409A (fi) 1992-01-17
KR920002154A (ko) 1992-02-28
LTIP920A (en) 1995-03-27
CA2047027C (en) 1996-09-17
HU206630B (en) 1992-12-28
RU2070040C1 (ru) 1996-12-10
DE4122167A1 (de) 1992-01-23
NO912771D0 (no) 1991-07-15
IL98836A0 (en) 1992-07-15
RO113713B1 (ro) 1998-10-30
BG94824A (bg) 1993-12-24
US5262169A (en) 1993-11-16
JP3068894B2 (ja) 2000-07-24
IE65373B1 (en) 1995-10-18
LV10040B (en) 1995-06-20
LT3527B (en) 1995-11-27
NZ238941A (en) 1993-03-26
NO912771L (no) 1992-01-17
HU912374D0 (en) 1991-12-30
CN1058337A (zh) 1992-02-05
DE59101431D1 (de) 1994-05-26
BG60851B1 (bg) 1996-05-31
ES2063412T3 (es) 1995-01-01
AU638586B2 (en) 1993-07-01
EP0468245A1 (de) 1992-01-29
BG96200A (bg) 1993-12-24
FI97949C (fi) 1997-03-25
HRP920889A2 (en) 1996-04-30
HRP920889B1 (en) 1998-02-28
SG142394G (en) 1995-01-13
EG20019A (en) 1997-01-30
NO178362B (no) 1995-12-04
JPH04230319A (ja) 1992-08-19
ATE104548T1 (de) 1994-05-15

Similar Documents

Publication Publication Date Title
ES2061623T3 (es) Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
GR3004643T3 (pt)
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
PE19496A1 (es) Formulacion de analogo de insulina humana
ES2068800T3 (es) Preparacion farmaceutica en forma de un comprimido efervescente y/o de descomposicion, o de un granulado instantaneo, asi como procedimiento para su fabricacion.
PT91108A (pt) Processo para a preparacao de uma composicao farmaceutica que compreende um ingrediente activo tal como um sal do acido colico e um produto inibidor para activar a absorcao do ingrediente activo pelo corpo humano
PT98325A (pt) Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna)
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
ES2029776T3 (es) Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con gran estabilidad y productos relacionados.
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
PT82512B (pt) Processo para a preparacao de derivados de quinolilglicinamidas com actividade psicotropica e de composicoes farmaceuticas que os contem
GB2021409A (en) Pharmaceutical composition
MX172107B (es) Procedimiento para la desinfeccion de masas para vaciado medicinales
ES556437A0 (es) Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos.
YU122691A (sh) Tablete i granulat koji kao aktivnu materiju sadrže natrijum-2-merkapto-etansulfonat
ES2077193T3 (es) Procedimiento de esterificacion de acidos hidroxibenzoicos.
ES2118845T3 (es) Proceso para la preparacion de trimetilaluminio por reaccion de cloruros de metilaluminio con sodio en reactores de estado solido.
SE8401856D0 (sv) New pharmaceutical preparations
GB1166958A (en) Process for Making Tablets Containing Aspirin and Salicylamide
YU46792B (sh) Kipuća tableta za dezinfekciju vode na bazi hloramina i postupak za njihovu proizvodnju
JPS5615208A (en) Remedy for trichophytosis
JI et al. THE EFFECTS OF DHA ON RATS MEMORY
TH14574A (th) สารผสมทางเภสัชกรรม
SU1774660A1 (ru) Способ получения меченного тритием простагландина f
TH13475A (th) สูตรผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920114

FG3A Patent granted, date of granting

Effective date: 19981002

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20131002